Abstract
We have shown that cardiac norepinephrine (NE) reuptake activity and tyrosine hydroxylase (TH), a rate-limiting enzyme for NE synthesis, are reduced in congestive heart failure (CHF). To determine whether the changes of TH are caused by neurotoxic effects of NE, we administered the neuronal uptake inhibitor desipramine (DMI, 225 mg/day) to pacing-induced CHF and sham-operated (SHAM) dogs for 6 weeks. CHF was characterized by tachycardia, low aortic pressure, elevated left atrial pressure, decreased left ventricular dP/dt and reduced cardiac output. DMI produced no hemodynamic effects. The effects of OMI on left ventricular NE uptake activity (fmol/mg/15 min) and immunocytochemical TH profiles were: Group NE uptake TH SHAM (n = 12) 133 ± 9 813 ± 43 SHAM + OMI (n = 6) 49 ± 11 * 769 ± 14 CHF (n = 12) 64 ± 8 * 409 ± 42 * CHF + OMI (n = 7) 40 ± 9 * , † 642 ± 49 * , † Values are mean ± SE * p < 005 vs. SHAM: † P < 0.05 vs. CHF As expected, DMI reduced NE uptake activity in both SHAM and CHF animals, but its actions on TH differed between the two groups. While it exerted no effect on TH in SHAM animals, DMI reduced the decrease in TH that occurred in CHF. The results suggest that the cardiac sympathetic changes that occur in CHF may be caused by excessive NE, and that the neurotoxic effect of NE on TH involves the NE reuptake mechanism.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.